nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.151	0.229	CbGbCtD
Oxybutynin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0779	0.118	CbGbCtD
Oxybutynin—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0755	0.114	CbGbCtD
Oxybutynin—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0726	0.11	CbGbCtD
Oxybutynin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.059	0.0894	CbGbCtD
Oxybutynin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0506	0.0767	CbGbCtD
Oxybutynin—CYP3A4—Prednisolone—ankylosing spondylitis	0.05	0.0757	CbGbCtD
Oxybutynin—CYP3A4—Prednisone—ankylosing spondylitis	0.0472	0.0715	CbGbCtD
Oxybutynin—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0463	0.0702	CbGbCtD
Oxybutynin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0295	0.0446	CbGbCtD
Oxybutynin—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000583	0.00172	CcSEcCtD
Oxybutynin—Drowsiness—Methotrexate—ankylosing spondylitis	0.000582	0.00171	CcSEcCtD
Oxybutynin—Infestation—Methotrexate—ankylosing spondylitis	0.000582	0.00171	CcSEcCtD
Oxybutynin—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000582	0.00171	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000581	0.00171	CcSEcCtD
Oxybutynin—Depression—Methotrexate—ankylosing spondylitis	0.000581	0.00171	CcSEcCtD
Oxybutynin—Flushing—Prednisone—ankylosing spondylitis	0.00058	0.00171	CcSEcCtD
Oxybutynin—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00058	0.00171	CcSEcCtD
Oxybutynin—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00058	0.00171	CcSEcCtD
Oxybutynin—Discomfort—Triamcinolone—ankylosing spondylitis	0.00058	0.0017	CcSEcCtD
Oxybutynin—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000578	0.0017	CcSEcCtD
Oxybutynin—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000574	0.00169	CcSEcCtD
Oxybutynin—Angioedema—Betamethasone—ankylosing spondylitis	0.000571	0.00168	CcSEcCtD
Oxybutynin—Angioedema—Dexamethasone—ankylosing spondylitis	0.000571	0.00168	CcSEcCtD
Oxybutynin—Stomatitis—Methotrexate—ankylosing spondylitis	0.000568	0.00167	CcSEcCtD
Oxybutynin—Angiopathy—Prednisone—ankylosing spondylitis	0.000567	0.00167	CcSEcCtD
Oxybutynin—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000566	0.00166	CcSEcCtD
Oxybutynin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000566	0.00166	CcSEcCtD
Oxybutynin—Malaise—Dexamethasone—ankylosing spondylitis	0.000564	0.00166	CcSEcCtD
Oxybutynin—Malaise—Betamethasone—ankylosing spondylitis	0.000564	0.00166	CcSEcCtD
Oxybutynin—Oedema—Triamcinolone—ankylosing spondylitis	0.000562	0.00165	CcSEcCtD
Oxybutynin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000562	0.00165	CcSEcCtD
Oxybutynin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000561	0.00165	CcSEcCtD
Oxybutynin—Syncope—Betamethasone—ankylosing spondylitis	0.000561	0.00165	CcSEcCtD
Oxybutynin—Syncope—Dexamethasone—ankylosing spondylitis	0.000561	0.00165	CcSEcCtD
Oxybutynin—Arrhythmia—Prednisone—ankylosing spondylitis	0.000559	0.00164	CcSEcCtD
Oxybutynin—Infection—Triamcinolone—ankylosing spondylitis	0.000559	0.00164	CcSEcCtD
Oxybutynin—Infection—Methylprednisolone—ankylosing spondylitis	0.000557	0.00164	CcSEcCtD
Oxybutynin—Haematuria—Methotrexate—ankylosing spondylitis	0.000555	0.00163	CcSEcCtD
Oxybutynin—Shock—Triamcinolone—ankylosing spondylitis	0.000553	0.00163	CcSEcCtD
Oxybutynin—Insomnia—Prednisolone—ankylosing spondylitis	0.000553	0.00163	CcSEcCtD
Oxybutynin—Shock—Methylprednisolone—ankylosing spondylitis	0.000552	0.00162	CcSEcCtD
Oxybutynin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00055	0.00162	CcSEcCtD
Oxybutynin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000549	0.00162	CcSEcCtD
Oxybutynin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000549	0.00162	CcSEcCtD
Oxybutynin—Epistaxis—Methotrexate—ankylosing spondylitis	0.000549	0.00162	CcSEcCtD
Oxybutynin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000549	0.00162	CcSEcCtD
Oxybutynin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000549	0.00161	CcSEcCtD
Oxybutynin—Mental disorder—Prednisone—ankylosing spondylitis	0.000548	0.00161	CcSEcCtD
Oxybutynin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000548	0.00161	CcSEcCtD
Oxybutynin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000545	0.0016	CcSEcCtD
Oxybutynin—Malnutrition—Prednisone—ankylosing spondylitis	0.000544	0.0016	CcSEcCtD
Oxybutynin—Erythema—Prednisone—ankylosing spondylitis	0.000544	0.0016	CcSEcCtD
Oxybutynin—Convulsion—Dexamethasone—ankylosing spondylitis	0.000542	0.00159	CcSEcCtD
Oxybutynin—Convulsion—Betamethasone—ankylosing spondylitis	0.000542	0.00159	CcSEcCtD
Oxybutynin—Hypertension—Dexamethasone—ankylosing spondylitis	0.00054	0.00159	CcSEcCtD
Oxybutynin—Hypertension—Betamethasone—ankylosing spondylitis	0.00054	0.00159	CcSEcCtD
Oxybutynin—Anxiety—Dexamethasone—ankylosing spondylitis	0.00053	0.00156	CcSEcCtD
Oxybutynin—Anxiety—Betamethasone—ankylosing spondylitis	0.00053	0.00156	CcSEcCtD
Oxybutynin—Discomfort—Dexamethasone—ankylosing spondylitis	0.000526	0.00155	CcSEcCtD
Oxybutynin—Discomfort—Betamethasone—ankylosing spondylitis	0.000526	0.00155	CcSEcCtD
Oxybutynin—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000524	0.00154	CcSEcCtD
Oxybutynin—Pain—Prednisolone—ankylosing spondylitis	0.000523	0.00154	CcSEcCtD
Oxybutynin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000519	0.00153	CcSEcCtD
Oxybutynin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000516	0.00152	CcSEcCtD
Oxybutynin—Vision blurred—Prednisone—ankylosing spondylitis	0.000513	0.00151	CcSEcCtD
Oxybutynin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000512	0.00151	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000512	0.00151	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000511	0.0015	CcSEcCtD
Oxybutynin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00051	0.0015	CcSEcCtD
Oxybutynin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00051	0.0015	CcSEcCtD
Oxybutynin—Oedema—Dexamethasone—ankylosing spondylitis	0.00051	0.0015	CcSEcCtD
Oxybutynin—Oedema—Betamethasone—ankylosing spondylitis	0.00051	0.0015	CcSEcCtD
Oxybutynin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000509	0.0015	CcSEcCtD
Oxybutynin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000507	0.00149	CcSEcCtD
Oxybutynin—Infection—Dexamethasone—ankylosing spondylitis	0.000507	0.00149	CcSEcCtD
Oxybutynin—Infection—Betamethasone—ankylosing spondylitis	0.000507	0.00149	CcSEcCtD
Oxybutynin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000505	0.00149	CcSEcCtD
Oxybutynin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000505	0.00149	CcSEcCtD
Oxybutynin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000504	0.00148	CcSEcCtD
Oxybutynin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000504	0.00148	CcSEcCtD
Oxybutynin—Visual impairment—Methotrexate—ankylosing spondylitis	0.000504	0.00148	CcSEcCtD
Oxybutynin—Shock—Dexamethasone—ankylosing spondylitis	0.000502	0.00148	CcSEcCtD
Oxybutynin—Shock—Betamethasone—ankylosing spondylitis	0.000502	0.00148	CcSEcCtD
Oxybutynin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.0005	0.00147	CcSEcCtD
Oxybutynin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.0005	0.00147	CcSEcCtD
Oxybutynin—Agitation—Prednisone—ankylosing spondylitis	0.0005	0.00147	CcSEcCtD
Oxybutynin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000498	0.00146	CcSEcCtD
Oxybutynin—Tachycardia—Betamethasone—ankylosing spondylitis	0.000498	0.00146	CcSEcCtD
Oxybutynin—Angioedema—Prednisone—ankylosing spondylitis	0.000497	0.00146	CcSEcCtD
Oxybutynin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000495	0.00146	CcSEcCtD
Oxybutynin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000494	0.00145	CcSEcCtD
Oxybutynin—Malaise—Prednisone—ankylosing spondylitis	0.000491	0.00144	CcSEcCtD
Oxybutynin—Eye disorder—Methotrexate—ankylosing spondylitis	0.000488	0.00144	CcSEcCtD
Oxybutynin—Syncope—Prednisone—ankylosing spondylitis	0.000488	0.00144	CcSEcCtD
Oxybutynin—Tinnitus—Methotrexate—ankylosing spondylitis	0.000487	0.00143	CcSEcCtD
Oxybutynin—Anorexia—Dexamethasone—ankylosing spondylitis	0.000486	0.00143	CcSEcCtD
Oxybutynin—Anorexia—Betamethasone—ankylosing spondylitis	0.000486	0.00143	CcSEcCtD
Oxybutynin—Urticaria—Prednisolone—ankylosing spondylitis	0.000486	0.00143	CcSEcCtD
Oxybutynin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000485	0.00143	CcSEcCtD
Oxybutynin—Fatigue—Triamcinolone—ankylosing spondylitis	0.000485	0.00143	CcSEcCtD
Oxybutynin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000484	0.00142	CcSEcCtD
Oxybutynin—Pain—Triamcinolone—ankylosing spondylitis	0.000481	0.00141	CcSEcCtD
Oxybutynin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000478	0.00141	CcSEcCtD
Oxybutynin—Hypotension—Dexamethasone—ankylosing spondylitis	0.000477	0.0014	CcSEcCtD
Oxybutynin—Hypotension—Betamethasone—ankylosing spondylitis	0.000477	0.0014	CcSEcCtD
Oxybutynin—Angiopathy—Methotrexate—ankylosing spondylitis	0.000474	0.00139	CcSEcCtD
Oxybutynin—Convulsion—Prednisone—ankylosing spondylitis	0.000472	0.00139	CcSEcCtD
Oxybutynin—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000471	0.00139	CcSEcCtD
Oxybutynin—Hypertension—Prednisone—ankylosing spondylitis	0.00047	0.00138	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000465	0.00137	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000465	0.00137	CcSEcCtD
Oxybutynin—Arthralgia—Prednisone—ankylosing spondylitis	0.000463	0.00136	CcSEcCtD
Oxybutynin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000463	0.00136	CcSEcCtD
Oxybutynin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000462	0.00136	CcSEcCtD
Oxybutynin—Anxiety—Prednisone—ankylosing spondylitis	0.000462	0.00136	CcSEcCtD
Oxybutynin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000461	0.00136	CcSEcCtD
Oxybutynin—Insomnia—Betamethasone—ankylosing spondylitis	0.000461	0.00136	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00046	0.00135	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000459	0.00135	CcSEcCtD
Oxybutynin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000458	0.00135	CcSEcCtD
Oxybutynin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000458	0.00135	CcSEcCtD
Oxybutynin—Discomfort—Prednisone—ankylosing spondylitis	0.000458	0.00135	CcSEcCtD
Oxybutynin—Mental disorder—Methotrexate—ankylosing spondylitis	0.000458	0.00135	CcSEcCtD
Oxybutynin—Malnutrition—Methotrexate—ankylosing spondylitis	0.000455	0.00134	CcSEcCtD
Oxybutynin—Erythema—Methotrexate—ankylosing spondylitis	0.000455	0.00134	CcSEcCtD
Oxybutynin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00045	0.00133	CcSEcCtD
Oxybutynin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000449	0.00132	CcSEcCtD
Oxybutynin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000449	0.00132	CcSEcCtD
Oxybutynin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000447	0.00131	CcSEcCtD
Oxybutynin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000446	0.00131	CcSEcCtD
Oxybutynin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000446	0.00131	CcSEcCtD
Oxybutynin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000444	0.00131	CcSEcCtD
Oxybutynin—Oedema—Prednisone—ankylosing spondylitis	0.000444	0.00131	CcSEcCtD
Oxybutynin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000444	0.0013	CcSEcCtD
Oxybutynin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000444	0.0013	CcSEcCtD
Oxybutynin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000444	0.0013	CcSEcCtD
Oxybutynin—Infection—Prednisone—ankylosing spondylitis	0.000441	0.0013	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00044	0.0013	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00044	0.0013	CcSEcCtD
Oxybutynin—Back pain—Methotrexate—ankylosing spondylitis	0.00044	0.00129	CcSEcCtD
Oxybutynin—Fatigue—Dexamethasone—ankylosing spondylitis	0.00044	0.00129	CcSEcCtD
Oxybutynin—Fatigue—Betamethasone—ankylosing spondylitis	0.00044	0.00129	CcSEcCtD
Oxybutynin—Shock—Prednisone—ankylosing spondylitis	0.000437	0.00129	CcSEcCtD
Oxybutynin—Pain—Betamethasone—ankylosing spondylitis	0.000436	0.00128	CcSEcCtD
Oxybutynin—Pain—Dexamethasone—ankylosing spondylitis	0.000436	0.00128	CcSEcCtD
Oxybutynin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000436	0.00128	CcSEcCtD
Oxybutynin—Tachycardia—Prednisone—ankylosing spondylitis	0.000434	0.00128	CcSEcCtD
Oxybutynin—Skin disorder—Prednisone—ankylosing spondylitis	0.000432	0.00127	CcSEcCtD
Oxybutynin—Vision blurred—Methotrexate—ankylosing spondylitis	0.000429	0.00126	CcSEcCtD
Oxybutynin—Anorexia—Prednisone—ankylosing spondylitis	0.000424	0.00125	CcSEcCtD
Oxybutynin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000422	0.00124	CcSEcCtD
Oxybutynin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00042	0.00124	CcSEcCtD
Oxybutynin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00042	0.00124	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000417	0.00123	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000417	0.00123	CcSEcCtD
Oxybutynin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000414	0.00122	CcSEcCtD
Oxybutynin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000413	0.00122	CcSEcCtD
Oxybutynin—Malaise—Methotrexate—ankylosing spondylitis	0.00041	0.00121	CcSEcCtD
Oxybutynin—Urticaria—Betamethasone—ankylosing spondylitis	0.000405	0.00119	CcSEcCtD
Oxybutynin—Urticaria—Dexamethasone—ankylosing spondylitis	0.000405	0.00119	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000405	0.00119	CcSEcCtD
Oxybutynin—Dizziness—Prednisolone—ankylosing spondylitis	0.000404	0.00119	CcSEcCtD
Oxybutynin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000403	0.00119	CcSEcCtD
Oxybutynin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000403	0.00119	CcSEcCtD
Oxybutynin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000403	0.00119	CcSEcCtD
Oxybutynin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000403	0.00118	CcSEcCtD
Oxybutynin—Insomnia—Prednisone—ankylosing spondylitis	0.000402	0.00118	CcSEcCtD
Oxybutynin—Paraesthesia—Prednisone—ankylosing spondylitis	0.000399	0.00117	CcSEcCtD
Oxybutynin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000398	0.00117	CcSEcCtD
Oxybutynin—Cough—Methotrexate—ankylosing spondylitis	0.000397	0.00117	CcSEcCtD
Oxybutynin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000397	0.00117	CcSEcCtD
Oxybutynin—Convulsion—Methotrexate—ankylosing spondylitis	0.000394	0.00116	CcSEcCtD
Oxybutynin—Dyspepsia—Prednisone—ankylosing spondylitis	0.000391	0.00115	CcSEcCtD
Oxybutynin—Chest pain—Methotrexate—ankylosing spondylitis	0.000387	0.00114	CcSEcCtD
Oxybutynin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000387	0.00114	CcSEcCtD
Oxybutynin—Decreased appetite—Prednisone—ankylosing spondylitis	0.000386	0.00114	CcSEcCtD
Oxybutynin—Rash—Prednisolone—ankylosing spondylitis	0.000386	0.00113	CcSEcCtD
Oxybutynin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000385	0.00113	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000385	0.00113	CcSEcCtD
Oxybutynin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000384	0.00113	CcSEcCtD
Oxybutynin—Fatigue—Prednisone—ankylosing spondylitis	0.000383	0.00113	CcSEcCtD
Oxybutynin—Headache—Prednisolone—ankylosing spondylitis	0.000383	0.00113	CcSEcCtD
Oxybutynin—Discomfort—Methotrexate—ankylosing spondylitis	0.000383	0.00113	CcSEcCtD
Oxybutynin—Constipation—Prednisone—ankylosing spondylitis	0.00038	0.00112	CcSEcCtD
Oxybutynin—Confusional state—Methotrexate—ankylosing spondylitis	0.000374	0.0011	CcSEcCtD
Oxybutynin—Dizziness—Triamcinolone—ankylosing spondylitis	0.000372	0.00109	CcSEcCtD
Oxybutynin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000371	0.00109	CcSEcCtD
Oxybutynin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000371	0.00109	CcSEcCtD
Oxybutynin—Infection—Methotrexate—ankylosing spondylitis	0.000369	0.00109	CcSEcCtD
Oxybutynin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000366	0.00108	CcSEcCtD
Oxybutynin—Asthenia—Dexamethasone—ankylosing spondylitis	0.000366	0.00108	CcSEcCtD
Oxybutynin—Asthenia—Betamethasone—ankylosing spondylitis	0.000366	0.00108	CcSEcCtD
Oxybutynin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000364	0.00107	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000363	0.00107	CcSEcCtD
Oxybutynin—Nausea—Prednisolone—ankylosing spondylitis	0.000363	0.00107	CcSEcCtD
Oxybutynin—Pruritus—Dexamethasone—ankylosing spondylitis	0.000361	0.00106	CcSEcCtD
Oxybutynin—Pruritus—Betamethasone—ankylosing spondylitis	0.000361	0.00106	CcSEcCtD
Oxybutynin—Skin disorder—Methotrexate—ankylosing spondylitis	0.000361	0.00106	CcSEcCtD
Oxybutynin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000358	0.00105	CcSEcCtD
Oxybutynin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000357	0.00105	CcSEcCtD
Oxybutynin—Rash—Triamcinolone—ankylosing spondylitis	0.000355	0.00104	CcSEcCtD
Oxybutynin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000354	0.00104	CcSEcCtD
Oxybutynin—Anorexia—Methotrexate—ankylosing spondylitis	0.000354	0.00104	CcSEcCtD
Oxybutynin—Rash—Methylprednisolone—ankylosing spondylitis	0.000354	0.00104	CcSEcCtD
Oxybutynin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000353	0.00104	CcSEcCtD
Oxybutynin—Urticaria—Prednisone—ankylosing spondylitis	0.000353	0.00104	CcSEcCtD
Oxybutynin—Headache—Triamcinolone—ankylosing spondylitis	0.000352	0.00104	CcSEcCtD
Oxybutynin—Headache—Methylprednisolone—ankylosing spondylitis	0.000351	0.00103	CcSEcCtD
Oxybutynin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000351	0.00103	CcSEcCtD
Oxybutynin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000349	0.00103	CcSEcCtD
Oxybutynin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000349	0.00103	CcSEcCtD
Oxybutynin—Hypotension—Methotrexate—ankylosing spondylitis	0.000347	0.00102	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000338	0.000995	CcSEcCtD
Oxybutynin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000337	0.000992	CcSEcCtD
Oxybutynin—Dizziness—Betamethasone—ankylosing spondylitis	0.000337	0.000992	CcSEcCtD
Oxybutynin—Insomnia—Methotrexate—ankylosing spondylitis	0.000336	0.000988	CcSEcCtD
Oxybutynin—Nausea—Triamcinolone—ankylosing spondylitis	0.000334	0.000983	CcSEcCtD
Oxybutynin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000333	0.000981	CcSEcCtD
Oxybutynin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000333	0.00098	CcSEcCtD
Oxybutynin—Somnolence—Methotrexate—ankylosing spondylitis	0.00033	0.000971	CcSEcCtD
Oxybutynin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000327	0.000963	CcSEcCtD
Oxybutynin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000327	0.000962	CcSEcCtD
Oxybutynin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000324	0.000954	CcSEcCtD
Oxybutynin—Vomiting—Betamethasone—ankylosing spondylitis	0.000324	0.000954	CcSEcCtD
Oxybutynin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000323	0.00095	CcSEcCtD
Oxybutynin—Rash—Dexamethasone—ankylosing spondylitis	0.000322	0.000946	CcSEcCtD
Oxybutynin—Rash—Betamethasone—ankylosing spondylitis	0.000322	0.000946	CcSEcCtD
Oxybutynin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000321	0.000945	CcSEcCtD
Oxybutynin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000321	0.000945	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000321	0.000943	CcSEcCtD
Oxybutynin—Fatigue—Methotrexate—ankylosing spondylitis	0.00032	0.000942	CcSEcCtD
Oxybutynin—Headache—Dexamethasone—ankylosing spondylitis	0.00032	0.00094	CcSEcCtD
Oxybutynin—Headache—Betamethasone—ankylosing spondylitis	0.00032	0.00094	CcSEcCtD
Oxybutynin—Asthenia—Prednisone—ankylosing spondylitis	0.000319	0.000938	CcSEcCtD
Oxybutynin—Pain—Methotrexate—ankylosing spondylitis	0.000318	0.000934	CcSEcCtD
Oxybutynin—Pruritus—Prednisone—ankylosing spondylitis	0.000314	0.000925	CcSEcCtD
Oxybutynin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000306	0.0009	CcSEcCtD
Oxybutynin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000304	0.000894	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000304	0.000893	CcSEcCtD
Oxybutynin—Nausea—Dexamethasone—ankylosing spondylitis	0.000303	0.000891	CcSEcCtD
Oxybutynin—Nausea—Betamethasone—ankylosing spondylitis	0.000303	0.000891	CcSEcCtD
Oxybutynin—Urticaria—Methotrexate—ankylosing spondylitis	0.000295	0.000868	CcSEcCtD
Oxybutynin—Dizziness—Prednisone—ankylosing spondylitis	0.000294	0.000864	CcSEcCtD
Oxybutynin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000294	0.000864	CcSEcCtD
Oxybutynin—Vomiting—Prednisone—ankylosing spondylitis	0.000283	0.000831	CcSEcCtD
Oxybutynin—Rash—Prednisone—ankylosing spondylitis	0.00028	0.000824	CcSEcCtD
Oxybutynin—Dermatitis—Prednisone—ankylosing spondylitis	0.00028	0.000823	CcSEcCtD
Oxybutynin—Headache—Prednisone—ankylosing spondylitis	0.000278	0.000819	CcSEcCtD
Oxybutynin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000274	0.000805	CcSEcCtD
Oxybutynin—Asthenia—Methotrexate—ankylosing spondylitis	0.000266	0.000784	CcSEcCtD
Oxybutynin—Nausea—Prednisone—ankylosing spondylitis	0.000264	0.000776	CcSEcCtD
Oxybutynin—Pruritus—Methotrexate—ankylosing spondylitis	0.000263	0.000773	CcSEcCtD
Oxybutynin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000254	0.000747	CcSEcCtD
Oxybutynin—Dizziness—Methotrexate—ankylosing spondylitis	0.000246	0.000722	CcSEcCtD
Oxybutynin—Vomiting—Methotrexate—ankylosing spondylitis	0.000236	0.000695	CcSEcCtD
Oxybutynin—Rash—Methotrexate—ankylosing spondylitis	0.000234	0.000689	CcSEcCtD
Oxybutynin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000234	0.000688	CcSEcCtD
Oxybutynin—Headache—Methotrexate—ankylosing spondylitis	0.000233	0.000684	CcSEcCtD
Oxybutynin—Nausea—Methotrexate—ankylosing spondylitis	0.000221	0.000649	CcSEcCtD
